Improving high-content-screening assay performance by using division-arrested cells

Assay and Drug Development Technologies

Volumn 3, Issue 5, 2005, Pages 515-523

  Vasudevan, Chandrasekaran ^a   Fursov, Natalie ^b   Maunder, Patrick ^a,d   Cong, Mei ^b   Federici, Mark ^c   Haskins, Jeffrey R ^a   Livelli, Thomas ^c   Zhong, Zhong ^c  

^a Cellomics Inc   (United States)

^b Cell and Molecular Technologies Inc   (United States)

^c Cell and Molecular Technologies   (United States)

^d Dendreon   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL CULTURE; CELL CYCLE; CELL DIVISION; CONTROLLED STUDY; CRYOPRESERVATION; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MITOSIS INHIBITION; QUALITY CONTROL; SCREENING TEST; SIGNAL NOISE RATIO;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HELA CELLS; HUMANS; KIDNEY; LETHAL DOSE 50; MITOMYCIN;

EID: 29244463856     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2005.3.515     Document Type: Article

References (13)

1. Johnston PA, Johnston PA: Cellular platforms for HTS: Three case studies. Drug Discov Today 2002;7:353-363.
2. Garippa RJ: A multi-faceted approach to the advancement of cell-based drug discovery. Drug Discov World 2005;6:43-50.
3. Cowan C, Ouellette M, Payne R, Hudson C, Eckhardt A, Oakley R: Process improvements in cell delivery for GPCR high throughput screening [abstract 503]. In 10th Society for Biomolecular Screening, Annual Conference and Exhibition, Orlando, FL, September 13, 2004.
4. Finnigan D, Surey D, King A, McLaren-Douglas A, Middleton B, Coote J, Rees S: Process improvements in cell delivery for GPCR high throughput screening. Cellular HTS using frozen cells: Uncoupling the link between cell supply and HTS [abstract 1204]. In 10th Society for Biomolecular Screening, Annual Conference and Exhibition, Orlando, FL, September 14, 2004.
5. Fursov N, Cong M, Federici M, Platchek M, Haytko P, Tacke R, Livelli T, Zhong Z: Improving consistency of cell-based assays by using division-arrested cell reagents. Assay Drug Dev Technol 2005;3:17-23.
6. Kanapuli P, Zheng W, Weber M, Solly K, Mull R, Platchek M, Cong M, Zhong Z, Strulovici B: Application of division-arrest technology to cell-based HTS: Comparison with frozen and fresh cells. Assay Drug Dev Technol 2005;3: 24-31.
7. Giuliano KA, Haskins JR, Taylor DL: Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-577.
8. Abraham VC, Taylor DL, Haskins JR: High content screening applied to large scale biology. Trends Biotechnol 2004;22:15-22.
9. Vakkila J, DeMarco RA, Lotze MT: Irnaging analysis of STAT1 and NF-kappaB translocation in dendritic cells at the single cell level. J Immunol Methods 2004;294:123-134.
10. Tosti E, Waldbaum L, Warshaw G, Gross EA, Ruggieri R: The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway. J Biol Chem 2004;279:47652-47660.
11. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4: 67-73.
12. Souchier C, Manel AM, Ffrench M, Treilleritouet D, Bryon PA: Nuclear texture during the cell cycle in acute lymphoid leukemia. In Vivo 1993;7:339-342.
13. Seo M, Lee YI, Cho CH, Bae CD, Kim lH, Juhnn YS: Bidirectional regulation of UV-induced activation of p38 kinase and c-Jun N-terminal kinase by G protein βγ subunits. J Biol Chem 2002;277:24197-24203.